Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€107.50

€107.50

-0.920%
-1.0
-0.920%
€172.32
 
30.07.25 / Tradegate WKN: 870980 / Symbol: RGEN / Name: Repligen Corp / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Repligen Corp. Stock

The price for the Repligen Corp. stock decreased slightly today. Compared to yesterday there is a change of -€1.000 (-0.920%).
With 17 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 172 € there is a hugely positive potential of 60.0% for Repligen Corp. compared to the current price of 107.5 €.
So far the community has only identified positive things for Repligen Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Repligen Corp. in the next few years

Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Repligen Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Repligen Corp. -0.920% 8.040% 1.799% -27.658% -23.187% -48.528% -15.884%
Opko Health Inc. 0.340% -2.544% 0.884% -12.746% -19.467% -52.501% -77.150%
Amicus Therapeutics Inc. 1.940% 0.000% 5.000% -43.243% -42.623% -47.844% -57.317%
Hutchison China Meditech Ltd 0.000% 12.950% 31.933% -0.633% 21.705% 34.188% -27.650%

Comments

Prediction Buy
Perf. (%) -0.05%
Target price 176.358
Change
Ends at 30.07.26

Repligen Corporation (NASDAQ: RGEN) had its price target raised by analysts at Royal Bank Of Canada from $193.00 to $204.00. They now have an "outperform" rating on the stock.
Ratings data for RGEN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.05%
Target price 151.288
Change
Ends at 30.07.26

Repligen Corporation (NASDAQ: RGEN) had its price target lowered by analysts at Wells Fargo & Company from $180.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for RGEN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 10.73%
Target price 136.864
Change
Ends at 22.07.26

Repligen Corporation (NASDAQ: RGEN) is now covered by analysts at Stephens. They set an "overweight" rating and a $160.00 price target on the stock.
Ratings data for RGEN provided by MarketBeat
Show more